Literature DB >> 2838374

Magnetic resonance imaging in the diagnosis of tumors of the liver.

Y Kinami1, H Yokota, M Takata, S Takashima, I Yamamoto.   

Abstract

To evaluate the usefulness of magnetic resonance (MR) imaging in the diagnosis of liver tumors, MR imaging was performed in 70 patients, 30 with normal or cirrhotic liver, 15 with benign tumors and 25 with malignant tumors. MR imaging was carried out with a 0.5-Tesla superconducting magnet and was made using a spin-echo technique, from which T1 and T2-weighted images were obtained, and also T1 and T2 values were measured. Hemangiomas and cysts were demonstrated as sharply circumscribed homogeneous masses of low- or high-intensity on each image. Hepatomas were revealed as low-, iso- and high-intensity masses on both images. The minimum size of hepatoma detected, 1 cm in diameter, exhibited uniform intensity. Large hepatomas showed a mosaic pattern of different intensities, a low-intensity area around the mass, and a capsular pattern. The majority of metastatic tumors demonstrated a characteristic irregularity at the periphery of the mass. There were significant differences in T1 and T2 values between benign and malignant tumors. These results suggest that MR imaging is useful not only in the detection but also in the differentiation of liver tumors and can permit evaluation of the architecture of the tumor.

Entities:  

Mesh:

Year:  1988        PMID: 2838374     DOI: 10.1007/BF02799025

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  16 in total

1.  Multiple NMR T2 relaxation values in human liver tissue.

Authors:  M E Bernardino; W Small; J Goldstein; C W Sewell; P J Sones; K Gedgaudas-McClees; J T Galambos; J Wenger; W J Casarella
Journal:  AJR Am J Roentgenol       Date:  1983-12       Impact factor: 3.959

2.  Work in progress: nuclear magnetic resonance imaging of the gallbladder.

Authors:  H Hricak; R A Filly; A R Margulis; K L Moon; L E Crooks; L Kaufman
Journal:  Radiology       Date:  1983-05       Impact factor: 11.105

3.  Nuclear magnetic resonance (NMR) imaging in the evaluation of the liver: a preliminary experience.

Authors:  G P Borkowski; E Buonocore; C R George; R T Go; P B O'Donovan; T F Meaney
Journal:  J Comput Assist Tomogr       Date:  1983-10       Impact factor: 1.826

4.  Gray scale ultrasound evaluation of hepatic neoplasms: patterns and correlations.

Authors:  B Green; R L Bree; H M Goldstein; C Stanley
Journal:  Radiology       Date:  1977-07       Impact factor: 11.105

5.  Hepatic metastases studied with MR and CT.

Authors:  J P Heiken; J K Lee; H S Glazer; D Ling
Journal:  Radiology       Date:  1985-08       Impact factor: 11.105

6.  The superselective and the selective one shot methods for treating inoperable cancer of the liver.

Authors:  Y Kinami; I Miyazaki
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

7.  Leo J. Rigler lecture. MR imaging of the liver.

Authors:  J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1986-12       Impact factor: 3.959

8.  Differential diagnosis of hepatic masses on computed tomography, with particular reference to hepatocellular carcinoma.

Authors:  Y Itai; T Araki; S Furui; A Tasaka
Journal:  J Comput Assist Tomogr       Date:  1981-12       Impact factor: 1.826

9.  Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.

Authors:  D D Stark; R C Felder; J Wittenberg; S Saini; R J Butch; M E White; R R Edelman; P R Mueller; J F Simeone; A M Cohen
Journal:  AJR Am J Roentgenol       Date:  1985-08       Impact factor: 3.959

10.  Hepatic tumors: magnetic resonance and CT appearance.

Authors:  A A Moss; H I Goldberg; D B Stark; P L Davis; A R Margulis; L Kaufman; L E Crooks
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

View more
  1 in total

Review 1.  Survey of water proton longitudinal relaxation in liver in vivo.

Authors:  John Charles Waterton
Journal:  MAGMA       Date:  2021-05-12       Impact factor: 2.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.